Press Releases

Ceapro Inc. Commences Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent

June 3, 2019

Ceapro Inc. Reports 2019 First Quarter Financial Results and Highlights

May 23, 2019

Ceapro Inc. Announces Receipt of Site License from Health Canada

May 15, 2019

Ceapro Inc. to Present at the ThinkEquity Conference in New York City

April 24, 2019

Ceapro Inc. Announces Positive Key Findings from Three Oral Presentations Given at European Meeting on Supercritical Fluids

April 15, 2019

Ceapro Inc. Reports Fourth Quarter and Full Year 2018 Results and Highlights

April 11, 2019

Ceapro Announces Acceptance of Abstract for Presentation at the 2019 American College of Sports Medicine Annual Meeting

March 27, 2019

Ceapro Inc. Announces Issuance of Indian Patent Application for Enabling Pressurized Gas eXpanded (PGX) Technology

March 25, 2019

Ceapro Inc. Announces Three Abstracts Selected for Oral Presentation at the 17th European Meeting on Supercritical Fluids (EMSF 2019)

February 26, 2019

Ceapro Announces 2019 Management Team and Grant of Stock Options and Restricted Share Units

January 7, 2019